Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
- NCT03869892
- CL3-95005-006, 2017-004059-22, U1111-1206-3198
Commercial Sponsor
Servier
Scientific Title
An Open-label, Randomised, Phase III Study comparing TrifLuridine/Tipiracil (S95005) in Combination With Bevacizumab to Capecitabine in Combination With Bevacizumab in first-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not candidate for Intensive Therapy